People everywhere are using AI to get creative, spend more time with loved ones and ditch mundane tasks — all things they wouldn’t have even imagined a year ago, before generative AI became widely ...

CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...